CORALVILLE, Iowa, May 18, 2016 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that KemPharm will host its annual meeting of stockholders on Tuesday, May 24, 2016, at 9:00 a.m. ET at the Harvard Club of New York City.
Information for KemPharm, Inc.’s Annual Meeting of Stockholders:
|Date:||Tuesday, May 24, 2016|
|Time:||9:00 a.m. (ET)|
|Location:||Harvard Club of New York City; Gordon Reading Room|
|27 West 44th Street, New York, NY 10036|
KemPharm is a clinical-stage specialty pharmaceutical company focused on the discovery and development of prodrugs to treat serious medical conditions through its Ligand Activated Therapy (LAT) platform technology. KemPharm utilizes its LAT platform technology to generate improved prodrug versions of FDA-approved drugs in the high need areas of pain, ADHD and other CNS disorders.
Investor Contacts: Jason Rando / Joshua Drumm, Ph.D. Tiberend Strategic Advisors, Inc. 212-375-2665 / 2664 firstname.lastname@example.org email@example.com Media Contact: Jim Heins Cooney Waters Unlimited 212-886-2221 firstname.lastname@example.org